Literature DB >> 9928907

31P magnetic resonance spectroscopy in the frontal lobe of major depressed patients.

H P Volz1, R Rzanny, S Riehemann, S May, H Hegewald, B Preussler, G Hübner, W A Kaiser, H Sauer.   

Abstract

Most research with 31P-magnetic resonance spectroscopy (31P-MRS) in affective disorders has been done in the field of bipolar disturbances. Reduced frontal and temporal lobe phosphomonoester (PME) concentrations were measured in the euthymic state, whereas increased values were found in the depressed state. In bipolar-II patients reduced phosphocreatine (PCr) concentrations were reported in the euthymic, depressed, and manic state. The aim of the present study was to explore whether PME and PCr were also altered in the frontal lobe of major depressed, unipolar patients. Therefore, we used 31P-MRS to investigate the relative phospholipid and high-energy phosphate concentrations in the frontal lobe of 14 unipolar patients, mostly medicated, and 8 age-matched controls. We found increased PME and decreased ATP values. Other 31P-MRS parameters were not different in both groups. Phosphomonoester percentages correlated negatively with the degree of depression. Thus, the main alterations found in bipolar depressed patients could also be demonstrated in unipolar depressed patients. The results are discussed with regard to disturbed phospholipid and intracellular high-energy phosphate metabolism in depressed patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9928907     DOI: 10.1007/s004060050052

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  35 in total

1.  Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.

Authors:  Douglas G Kondo; Young-Hoon Sung; Tracy L Hellem; Kristen K Fiedler; Xianfeng Shi; Eun-Kee Jeong; Perry F Renshaw
Journal:  J Affect Disord       Date:  2011-08-09       Impact factor: 4.839

2.  Incidence of major depressive episode correlates with elevation of substate region of residence.

Authors:  Kristen DelMastro; Tracy Hellem; Namkug Kim; Douglas Kondo; Young-Hoon Sung; Perry F Renshaw
Journal:  J Affect Disord       Date:  2010-11-11       Impact factor: 4.839

Review 3.  Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders.

Authors:  Stephen R Dager; Neva M Corrigan; Todd L Richards; Stefan Posse
Journal:  Top Magn Reson Imaging       Date:  2008-04

Review 4.  A mitochondrial bioenergetic basis of depression.

Authors:  N Jennifer Klinedinst; William T Regenold
Journal:  J Bioenerg Biomembr       Date:  2014-09-28       Impact factor: 2.945

5.  Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Pharmacol Biochem Behav       Date:  2012-03-10       Impact factor: 3.533

6.  Tissue Type-Specific Bioenergetic Abnormalities in Adults with Major Depression.

Authors:  David G Harper; J Eric Jensen; Caitlin Ravichandran; Roy H Perlis; Maurizio Fava; Perry F Renshaw; Dan V Iosifescu
Journal:  Neuropsychopharmacology       Date:  2016-09-02       Impact factor: 7.853

7.  Effects of dietary-induced alterations in rat brain docosahexaenoic acid accrual on phospholipid metabolism and mitochondrial bioenergetics: An in vivo31P MRS study.

Authors:  Diana M Lindquist; Ruth H Asch; Jennifer D Schurdak; Robert K McNamara
Journal:  J Psychiatr Res       Date:  2017-08-24       Impact factor: 4.791

8.  An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women.

Authors:  Brent M Kious; Hana Sabic; Young-Hoon Sung; Douglas G Kondo; Perry Renshaw
Journal:  J Clin Psychopharmacol       Date:  2017-10       Impact factor: 3.153

Review 9.  Review of transcranial photobiomodulation for major depressive disorder: targeting brain metabolism, inflammation, oxidative stress, and neurogenesis.

Authors:  Paolo Cassano; Samuel R Petrie; Michael R Hamblin; Theodore A Henderson; Dan V Iosifescu
Journal:  Neurophotonics       Date:  2016-03-04       Impact factor: 3.593

10.  Signal enhancement through heteronuclear polarisation transfer in in-vivo 31P MR spectroscopy of the human brain.

Authors:  W Weber-Fahr; P Bachert; F A Henn; D F Braus; G Ende
Journal:  MAGMA       Date:  2003-07-16       Impact factor: 2.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.